Tempest Therapeutics Files 424B3 Prospectus
Ticker: TPST · Form: 424B3 · Filed: Apr 10, 2026 · CIK: 0001544227
| Field | Detail |
|---|---|
| Company | Tempest Therapeutics, Inc. (TPST) |
| Form Type | 424B3 |
| Filed Date | Apr 10, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, securities-offering, filing
TL;DR
Tempest Therapeutics dropped a 424B3 filing on 4/10/26. Check it for new security info.
AI Summary
Tempest Therapeutics, Inc. filed a 424B3 prospectus on April 10, 2026, related to its securities. The filing details information about the company's offerings and operations, with its principal executive offices located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
Why It Matters
This filing provides updated information to investors regarding Tempest Therapeutics' securities, which could influence investment decisions and market perception.
Risk Assessment
Risk Level: low — A 424B3 filing is a standard prospectus supplement and does not inherently indicate increased risk for the company.
Key Numbers
- 0001193125-26-150469 — SEC Accession Number (Unique identifier for this specific SEC filing)
- 333-294740 — File Number (Associated file number for the registration statement)
Key Players & Entities
- Tempest Therapeutics, Inc. (company) — Filer of the prospectus
- 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005 (location) — Company's business and mailing address
- 0001544227 (company_id) — CIK number for Tempest Therapeutics, Inc.
- 2026-04-10 (date) — Filing date of the 424B3 prospectus
FAQ
What is the purpose of a 424B3 filing?
A 424B3 filing is a prospectus supplement used to provide additional information or updates to an already filed registration statement, often detailing the terms of securities being offered.
When was this specific 424B3 filing submitted by Tempest Therapeutics?
This 424B3 filing was submitted on April 10, 2026.
What is the CIK number for Tempest Therapeutics, Inc.?
The CIK number for Tempest Therapeutics, Inc. is 0001544227.
Where are Tempest Therapeutics' principal executive offices located?
Tempest Therapeutics' principal executive offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
What SIC code is associated with Tempest Therapeutics?
Tempest Therapeutics is associated with SIC code 2834, which pertains to Pharmaceutical Preparations.
Filing Details
This Form 424B3 (Form 424B3) was filed with the SEC on April 10, 2026 regarding Tempest Therapeutics, Inc. (TPST).